School of Psychology, The University of Queensland, Brisbane, QLD, Australia.
School of Applied Psychology and Center for Mental Health, Griffith University, Brisbane, QLD, Australia.
J Psychopharmacol. 2024 Aug;38(8):749-760. doi: 10.1177/02698811241265762. Epub 2024 Jul 29.
This study explores how individuals self-treat psychiatric conditions with psychedelics outside medical guidance bridging the gap in understanding unregulated therapeutic use.
The primary objective was to extract specific factors underlying the effects of psychedelics, exploring their relationship with the need for medication, particularly for mental health conditions like depression and anxiety. Additionally, we aimed to understand how the likelihood of being prescribed pharmacological medication varies based on mental health diagnoses and demographic factors.
This research utilised the Global Drug Survey 2020, an annual online survey focused on substance use patterns and demographics, incorporating modules addressing mental health and psychedelic use. The study employed Exploratory Factor Analysis to discern latent factors underlying the self-reported effects of psychedelics. Bivariable and multivariable logistic regressions were conducted to investigate the association between identified factors and the likelihood of current prescribed medication usage.
In all, 2552 respondents reported using psychedelics for self-treatment of mental health conditions. Three significant factors were identified: Improved Mental Health, Improved Self-Awareness and Neuro-Sensory Changes. The majority of the sample reported a history of depression (80%) or anxiety (65.6%), with a significant association observed between reported factors of psychedelics' effects and current medication usage for mental health, especially notable in cases of depression or comorbid depression and anxiety.
Perceived symptom improvement following psychedelic self-treatment may reduce the need for medically supervised pharmacological interventions. These findings highlight the potential of psychedelics to positively influence mental health and self-awareness, paving the way for further research into their therapeutic application.
本研究探讨了个体在医学指导之外如何自行使用迷幻药物治疗精神疾病,旨在填补对无监管治疗用途理解的空白。
主要目的是提取迷幻药物作用背后的具体因素,探索它们与药物需求的关系,特别是对于抑郁症和焦虑症等心理健康状况。此外,我们还旨在了解根据心理健康诊断和人口统计学因素,被开处药理学药物的可能性如何变化。
本研究利用了 2020 年全球毒品调查,这是一项年度在线调查,侧重于物质使用模式和人口统计学,其中包含了心理健康和迷幻药物使用的模块。研究采用探索性因素分析来辨别迷幻药物自我报告效果背后的潜在因素。进行了双变量和多变量逻辑回归,以调查确定因素与当前规定药物使用的可能性之间的关联。
共有 2552 名受访者报告称使用迷幻药物自行治疗心理健康状况。确定了三个重要因素:改善心理健康、提高自我意识和神经感觉变化。大多数样本报告了抑郁(80%)或焦虑(65.6%)的病史,迷幻药物效果报告因素与心理健康的当前药物使用之间存在显著关联,尤其是在抑郁或抑郁和焦虑共病的情况下。
迷幻药物自我治疗后感知症状的改善可能减少对医学监督药理学干预的需求。这些发现强调了迷幻药物对心理健康和自我意识产生积极影响的潜力,为进一步研究其治疗应用铺平了道路。